Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-006082
Filing Date
2021-02-11
Accepted
2021-02-11 21:04:40
Documents
2
Period of Report
2021-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3553
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4726
  Complete submission text file 0000899243-21-006082.txt   9649
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Issuer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address
Vigliotta Ronald (Reporting) CIK: 0001842142 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40030 | Film No.: 21622144